Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Etidocaine is a long-acting amide-type local anesthetic primarily used for infiltration anesthesia and peripheral nerve blocks during surgical procedures, labor, and delivery. It is administered by injection and has a rapid onset with a longer duration of action compared to lidocaine. Etidocaine works by binding to the α subunit of voltage-gated sodium channels in neuronal membranes, thereby blocking the generation and conduction of nerve impulses. Its main disadvantage is an increased risk of intraoperative and postoperative bleeding due to vasodilatory effects, especially in dental surgery. Etidocaine is metabolized hepatically and excreted renally[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on etidocaine.